Managing Neuropathic Pain in Dogs

Area of Science:

• Veterinary Medicine
• Neuroscience
• Pharmacology

Background:

• Neuropathic pain, common in humans with chronic diseases, is often overlooked in veterinary patients.
• Assessment difficulties arise as animals cannot self-report pain, unlike human patients.
• Veterinary curricula may lack comprehensive coverage of neuropathic pain mechanisms and recognition.

Purpose of the Study:

• To review the pathophysiology of neuropathic pain in dogs.
• To define key clinical terms associated with neuropathic pain.
• To discuss current pharmacological treatment options for neuropathic pain in dogs.

Main Methods:

• Review of existing literature on neuropathic pain mechanisms.
• Discussion of pharmacological agents used in veterinary practice.
• Examination of drug mechanisms of action and pharmacokinetics in dogs.

Main Results:

• Neuropathic pain involves ectopic afferent activity, sensitization, and glial activation.
• Commonly used drugs include gabapentin, pregabalin, amantadine, and amitriptyline.
• While human data is robust, veterinary-specific evidence for these treatments is limited.

Conclusions:

• Understanding neuropathic pain mechanisms is crucial for veterinary diagnosis and treatment.
• Pharmacological interventions targeting specific mechanisms offer therapeutic potential for dogs.
• Further research is needed for objective pain assessment and treatment monitoring in veterinary patients.